Jilin Aodong Pharmaceutical Group Co Ltd
Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in … Read more
Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Total Liabilities
Latest total liabilities as of September 2025: CN¥3.76 Billion CNY
Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has total liabilities worth CN¥3.76 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Jilin Aodong Pharmaceutical Group Co Ltd - Total Liabilities Trend (1993–2024)
This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hubei Zhenhua Chemical Co Ltd
SHG:603067
|
China | CN¥1.83 Billion |
|
Beijing Orient Landscape Co Ltd
SHE:002310
|
China | CN¥1.84 Billion |
|
OrangePL
WAR:OPL
|
Poland | zł13.78 Billion |
|
PTT Global Chemical Public Company Limited
OTCGREY:PTGCF
|
USA | $310.60 Billion |
|
Luoyang Xinqianglian Slewing Bearin
SHE:300850
|
China | CN¥4.40 Billion |
|
G-bits Network Technology Xiamen Co Ltd
SHG:603444
|
China | CN¥1.80 Billion |
Liability Composition Analysis (1993–2024)
This chart breaks down Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.14 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jilin Aodong Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jilin Aodong Pharmaceutical Group Co Ltd (1993–2024)
The table below shows the annual total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥3.72 Billion | -21.96% |
| 2023-12-31 | CN¥4.77 Billion | -1.36% |
| 2022-12-31 | CN¥4.83 Billion | +19.95% |
| 2021-12-31 | CN¥4.03 Billion | +5.35% |
| 2020-12-31 | CN¥3.82 Billion | +13.94% |
| 2019-12-31 | CN¥3.36 Billion | -1.70% |
| 2018-12-31 | CN¥3.41 Billion | +159.05% |
| 2017-12-31 | CN¥1.32 Billion | -10.13% |
| 2016-12-31 | CN¥1.47 Billion | -34.84% |
| 2015-12-31 | CN¥2.25 Billion | +102.65% |
| 2014-12-31 | CN¥1.11 Billion | -23.45% |
| 2013-12-31 | CN¥1.45 Billion | +20.08% |
| 2012-12-31 | CN¥1.21 Billion | +22.54% |
| 2011-12-31 | CN¥985.86 Million | +51.11% |
| 2010-12-31 | CN¥652.43 Million | +8.41% |
| 2009-12-31 | CN¥601.83 Million | -5.18% |
| 2008-12-31 | CN¥634.74 Million | -14.79% |
| 2007-12-31 | CN¥744.94 Million | -20.97% |
| 2006-12-31 | CN¥942.62 Million | +13.59% |
| 2005-12-31 | CN¥829.84 Million | -6.77% |
| 2004-12-31 | CN¥890.13 Million | +48.31% |
| 2003-12-31 | CN¥600.19 Million | -8.60% |
| 2002-12-31 | CN¥656.68 Million | +77.54% |
| 2001-12-31 | CN¥369.87 Million | +13.74% |
| 2000-12-31 | CN¥325.19 Million | -30.62% |
| 1999-12-31 | CN¥468.69 Million | +120.64% |
| 1998-12-31 | CN¥212.43 Million | -5.81% |
| 1997-12-31 | CN¥225.52 Million | +26.44% |
| 1996-12-31 | CN¥178.36 Million | +23.63% |
| 1995-12-31 | CN¥144.27 Million | +6.66% |
| 1994-12-31 | CN¥135.27 Million | +15.88% |
| 1993-12-31 | CN¥116.73 Million | -- |